Vanguard Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-579,507
| Closed | -$2.16M | – | 4380 |
|
|
2024
Q3 | $2.16M | Buy |
579,507
+15,111
| +3% | +$56.4K | ﹤0.01% | 3535 |
|
|
2024
Q2 | $3.16M | Sell |
564,396
-76,358
| -12% | -$428K | ﹤0.01% | 3421 |
|
|
2024
Q1 | $3.36M | Buy |
640,754
+2,630
| +0.4% | +$13.8K | ﹤0.01% | 3435 |
|
|
2023
Q4 | $3.34M | Sell |
638,124
-5,473
| -0.9% | -$28.6K | ﹤0.01% | 3428 |
|
|
2023
Q3 | $10.1M | Buy |
643,597
+21,911
| +4% | +$346K | ﹤0.01% | 2867 |
|
|
2023
Q2 | $12.1M | Sell |
621,686
-135,046
| -18% | -$2.63M | ﹤0.01% | 2833 |
|
|
2023
Q1 | $21.5M | Sell |
756,732
-7,075
| -0.9% | -$201K | ﹤0.01% | 2556 |
|
|
2022
Q4 | $22.3M | Sell |
763,807
-11,708
| -2% | -$342K | ﹤0.01% | 2572 |
|
|
2022
Q3 | $20.5M | Buy |
775,515
+3,756
| +0.5% | +$99.2K | ﹤0.01% | 2613 |
|
|
2022
Q2 | $34.3M | Sell |
771,759
-9,092
| -1% | -$404K | ﹤0.01% | 2374 |
|
|
2022
Q1 | $38.6M | Buy |
780,851
+20,383
| +3% | +$1.01M | ﹤0.01% | 2434 |
|
|
2021
Q4 | $38.7M | Sell |
760,468
-2,598
| -0.3% | -$132K | ﹤0.01% | 2493 |
|
|
2021
Q3 | $42.6M | Buy |
763,066
+9,786
| +1% | +$546K | ﹤0.01% | 2449 |
|
|
2021
Q2 | $32.2M | Sell |
753,280
-19,787
| -3% | -$847K | ﹤0.01% | 2592 |
|
|
2021
Q1 | $32.3M | Buy |
773,067
+8,132
| +1% | +$339K | ﹤0.01% | 2544 |
|
|
2020
Q4 | $35.6M | Buy |
764,935
+26,026
| +4% | +$1.21M | ﹤0.01% | 2370 |
|
|
2020
Q3 | $31.4M | Buy |
738,909
+5,965
| +0.8% | +$253K | ﹤0.01% | 2254 |
|
|
2020
Q2 | $35.2M | Sell |
732,944
-6,858
| -0.9% | -$329K | ﹤0.01% | 2178 |
|
|
2020
Q1 | $34M | Sell |
739,802
-20,568
| -3% | -$946K | ﹤0.01% | 2044 |
|
|
2019
Q4 | $45.7M | Buy |
760,370
+267
| +0% | +$16K | ﹤0.01% | 2155 |
|
|
2019
Q3 | $43M | Buy |
760,103
+6,629
| +0.9% | +$375K | ﹤0.01% | 2139 |
|
|
2019
Q2 | $42M | Sell |
753,474
-2,099
| -0.3% | -$117K | ﹤0.01% | 2193 |
|
|
2019
Q1 | $38.2M | Buy |
755,573
+27,164
| +4% | +$1.37M | ﹤0.01% | 2226 |
|
|
2018
Q4 | $29.3M | Buy |
728,409
+53,458
| +8% | +$2.15M | ﹤0.01% | 2271 |
|
|
2018
Q3 | $46.8M | Buy |
674,951
+59,474
| +10% | +$4.12M | ﹤0.01% | 2175 |
|
|
2018
Q2 | $46.6M | Buy |
615,477
+36,197
| +6% | +$2.74M | ﹤0.01% | 2162 |
|
|
2018
Q1 | $30.5M | Buy |
579,280
+9,486
| +2% | +$500K | ﹤0.01% | 2331 |
|
|
2017
Q4 | $30.4M | Buy |
569,794
+3,819
| +0.7% | +$204K | ﹤0.01% | 2312 |
|
|
2017
Q3 | $33.8M | Buy |
565,975
+4,155
| +0.7% | +$248K | ﹤0.01% | 2247 |
|
|
2017
Q2 | $44.3M | Buy |
561,820
+103,760
| +23% | +$8.19M | ﹤0.01% | 2069 |
|
|
2017
Q1 | $38M | Buy |
458,060
+29,339
| +7% | +$2.43M | ﹤0.01% | 2135 |
|
|
2016
Q4 | $34M | Buy |
428,721
+8,060
| +2% | +$639K | ﹤0.01% | 2159 |
|
|
2016
Q3 | $29.4M | Buy |
420,661
+58,052
| +16% | +$4.06M | ﹤0.01% | 2182 |
|
|
2016
Q2 | $14.1M | Buy |
362,609
+10,933
| +3% | +$424K | ﹤0.01% | 2487 |
|
|
2016
Q1 | $14.2M | Sell |
351,676
-6,997
| -2% | -$283K | ﹤0.01% | 2435 |
|
|
2015
Q4 | $31.8M | Sell |
358,673
-215,278
| -38% | -$19.1M | ﹤0.01% | 2104 |
|
|
2015
Q3 | $42.5M | Buy |
573,951
+258,554
| +82% | +$19.1M | ﹤0.01% | 1949 |
|
|
2015
Q2 | $25.5M | Buy |
315,397
+112,942
| +56% | +$9.13M | ﹤0.01% | 2249 |
|
|
2015
Q1 | $8.48M | Buy |
202,455
+167,513
| +479% | +$7.02M | ﹤0.01% | 2725 |
|
|
2014
Q4 | $542K | Buy |
34,942
+1,710
| +5% | +$26.5K | ﹤0.01% | 3702 |
|
|
2014
Q3 | $420K | Buy |
33,232
+20,980
| +171% | +$265K | ﹤0.01% | 3764 |
|
|
2014
Q2 | $176K | Buy |
+12,252
| New | +$176K | ﹤0.01% | 3871 |
|